NCT02509598 2024-06-28
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
Cardinal Health 414, LLC
Phase 2 Completed
Clinical Trials
5 trialsNCT04663126 2023-12-13
Tilmanocept
University of Lausanne Hospitals
Phase EARLY_PHASE1 Terminated
NCT04261179 2020-02-20
SENTINELSEEK
Fundacion Clinic per a la Recerca Biomédica
Phase 4 Unknown
NCT00671918 2013-06-17
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
Navidea Biopharmaceuticals
Phase 3 Completed
NCT01106040 2013-06-17
Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
Navidea Biopharmaceuticals
Phase 3 Completed